Results 11 to 20 of about 509 (152)

Ayahuasca: A review of historical, pharmacological, and therapeutic aspects

open access: yesPCN Reports, 2023
Ayahuasca is a psychedelic plant brew originating from the Amazon rainforest. It is formed from two basic components, the Banisteriopsis caapi vine and a plant containing the potent psychedelic dimethyltryptamine (DMT), usually Psychotria viridis.
Simon G. D. Ruffell   +15 more
doaj   +2 more sources

Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease. [PDF]

open access: yesJ Ethnopharmacol, 2010
Parkinson's disease is a neurological disorder mostly effecting the elder population of the world. Currently there is no definitive treatment or cure for this disease. Therefore, in this study the composition and constituents of the aqueous extract of Banisteriopsis caapi for monoamine oxidases (MAO) inhibitory and antioxidant activities were assessed,
Samoylenko V   +9 more
europepmc   +4 more sources

The complete chloroplast genomes of four Aspidopterys species and a comparison with other Malpighiaceae species [PDF]

open access: yesScientific Reports
The genus Aspidopterys has multiple functions in medicine, food and ecological restoration. Due to the similar morphological characteristics of some species and the limited genomic information hinder the studies on germplasm identification and molecular ...
He Liao, Huayuan Chen, Shinan Liu
doaj   +2 more sources

Diversity and genetic structure of mariri tucunacá (Banisteriopsis caapi) populations in the southern Brazilian Amazon rainforest [PDF]

open access: yesActa Amazonica
The Brazilian Amazon plays a vital role in global biodiversity, harboring species such as Banisteriopsis caapi, known for its cultural and medicinal significance.
Arielen Barreto de CARVALHO   +7 more
doaj   +4 more sources

The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress [PDF]

open access: yesPharmaceuticals
The psychedelic beverage ayahuasca is originally obtained by Banisteriopsis caapi (B. caapi) (BC) and Psychotria viridis (P. viridis) (PV). However, sometimes these plant species are replaced by others that mimic the original effects, such as Mimosa ...
Joana Gonçalves   +5 more
doaj   +2 more sources

Efecto de la ingestión de Banisteriopsis caapi y Psychotria viridis ‘Binomio ayahuasca’ en el hipocampo del cerebro de ratas

open access: yesAnales de la Facultad de Medicina, 2016
Objetivo. Evaluar el efecto de la ingestión de Banisteriopsis caapi y Psychotria viridis ‘Binomio ayahuasca’ en el hipocampo de cerebro de ratas. Diseño. Estudio experimental, descriptivo, analítico, transversal. Institución.
Américo Castro   +14 more
doaj   +3 more sources

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind [PDF]

open access: yesBiomedicines
In recent years, psychopharmacology has experienced a significant challenge, highlighting a renewed and strong scientific interest in psychedelics as breakthrough therapies for mental disorders.
Alice Melani   +9 more
doaj   +2 more sources

REVALORACIÓN ANCESTRAL DE LA (Banisteriopsis caapi) AYAHUASCA MEDIANTE LA PRODUCCIÓN DE PLANTONES EN LA UNIVERSIDAD NACIONAL INTERCULTURAL DE LA AMAZONIA

open access: yesTzhoecoen, 2019
El presenta trabajo de investigación se desarrolló en las instalaciones de la universidad nacional intercultural de la amazonia provincia de coronel portillo distrito de Yarinacocha en el año 2017, el objetivo fue  proponer e incentivar la repoblación de
Edwin Miranda Ruiz   +3 more
doaj   +2 more sources

Resilience and Brain Changes in Long-Term Ayahuasca Users: Insights From Psychometric and fMRI Pattern Recognition. [PDF]

open access: yesJ Magn Reson Imaging
ABSTRACT Background Ayahuasca is an Amazonian psychedelic brew that contains dimethyltryptamine (DMT) and beta carbolines. Prolonged use has shown changes in cognitive‐behavioral tasks, and in humans, there is evidence of changes in cortical thickness and an increase in neuroplasticity factors that could lead to modifications in functional neural ...
Ramos LR, Fernandes O, Sanchez TA.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy